Malignant fat-forming solitary fibrous tumor (so-called "lipomatous hemangiopericytoma"): clinicopathologic analysis of 14 cases

Am J Surg Pathol. 2011 Aug;35(8):1177-85. doi: 10.1097/PAS.0b013e318219cd0b.

Abstract

Fat-forming solitary fibrous tumor is a rare variant of solitary fibrous tumor (SFT). Generally regarded as benign, very few fat-forming SFTs with malignant histologic features have been reported. Here, we report 14 histologically malignant fat-forming SFTs to better characterize this subset. Seven patients were female and 7 were male, with ages ranging 20 to 93 years (median, 57 y). Five tumors were located in the lower limb, 3 in the trunk, 3 in abdominopelvic locations, 2 in the head and neck region, and 1 in the upper limb. The tumor size ranged from 3.4 to 20 cm (median, 8.6 cm). Histologically, all exhibited at least focal hypercellularity; 12 tumors had mitoses >4/10 high-power fields (range, 2 to 37; median, 8), 12 showed at least moderate atypia, and 8 showed necrosis. It should be noted that 7 tumors contained only mature adipose tissue, whereas 5 contained multivacuolated lipoblasts and 2 had areas resembling atypical lipomatous tumor (ALT). Immunohistochemically, CD34 and CD99 were positive in most cases (11 of 14 and 8 of 10, respectively); MDM2 and CDK4 were both negative in all 4 cases tested (including both tumors with ALT-like areas). Follow-up data from 10 cases (median duration, 47.5 mo; range, 5 to 76) showed 2 patients with multiple metastases (both to lung and bones, and 1 each to breast and to soft tissue), both of whom died of disease. In conclusion, fat-forming SFTs exhibiting malignant histologic features have potential for aggressive behavior. The presence of lipoblasts and/or ALT-like areas, although described in some "benign" examples of fat-forming SFT, seems much more common in the malignant subset and may prompt a careful search for morphologic evidence of malignancy in any case of fat-forming SFT.

MeSH terms

  • Abdominal Neoplasms / chemistry
  • Abdominal Neoplasms / mortality
  • Abdominal Neoplasms / pathology*
  • Abdominal Neoplasms / therapy
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Extremities
  • Female
  • Head and Neck Neoplasms / chemistry
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology*
  • Head and Neck Neoplasms / therapy
  • Hemangiopericytoma / chemistry
  • Hemangiopericytoma / mortality
  • Hemangiopericytoma / pathology*
  • Hemangiopericytoma / secondary
  • Hemangiopericytoma / therapy
  • Humans
  • Immunohistochemistry
  • Lipoma / chemistry
  • Lipoma / mortality
  • Lipoma / pathology*
  • Lipoma / therapy
  • Male
  • Middle Aged
  • Rectal Neoplasms / chemistry
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / secondary
  • Rectal Neoplasms / therapy
  • Soft Tissue Neoplasms / chemistry
  • Soft Tissue Neoplasms / mortality
  • Soft Tissue Neoplasms / pathology*
  • Soft Tissue Neoplasms / therapy
  • Solitary Fibrous Tumors / chemistry
  • Solitary Fibrous Tumors / mortality
  • Solitary Fibrous Tumors / pathology*
  • Solitary Fibrous Tumors / secondary
  • Solitary Fibrous Tumors / therapy
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Biomarkers, Tumor

Supplementary concepts

  • Lipomatous hemangiopericytoma